|
WO2010028347A2
(en)
|
2008-09-05 |
2010-03-11 |
President & Fellows Of Harvard College |
Continuous directed evolution of proteins and nucleic acids
|
|
EP2580331A4
(en)
*
|
2010-06-14 |
2013-11-27 |
Univ Iowa State Res Found Inc |
NUCLEASE ACTIVITY OF THE TAL EFFECTOR AND FUSION PROTEIN FOKI
|
|
WO2012088381A2
(en)
|
2010-12-22 |
2012-06-28 |
President And Fellows Of Harvard College |
Continuous directed evolution
|
|
US20140274812A1
(en)
|
2011-07-15 |
2014-09-18 |
The General Hospital Corporation |
Methods of Transcription Activator Like Effector Assembly
|
|
EP3613852A3
(en)
|
2011-07-22 |
2020-04-22 |
President and Fellows of Harvard College |
Evaluation and improvement of nuclease cleavage specificity
|
|
US20150017728A1
(en)
*
|
2011-09-23 |
2015-01-15 |
Iowa State University Research Foundation, Inc |
Monomer architecture of tal nuclease or zinc finger nuclease for dna modification
|
|
EP2776560A2
(en)
|
2011-11-07 |
2014-09-17 |
The University of Western Ontario |
Endonuclease for genome editing
|
|
HK1200871A1
(en)
|
2011-11-16 |
2015-08-14 |
Sangamo Therapeutics, Inc. |
Modified dna-binding proteins and uses thereof
|
|
US9688997B2
(en)
|
2011-12-29 |
2017-06-27 |
Iowa State University Research Foundation, Inc. |
Genetically modified plants with resistance to Xanthomonas and other bacterial plant pathogens
|
|
EP3141259B1
(en)
*
|
2012-03-15 |
2019-07-31 |
Cellectis |
Repeat variable diresidues for targeting nucleotides
|
|
US10704021B2
(en)
|
2012-03-15 |
2020-07-07 |
Flodesign Sonics, Inc. |
Acoustic perfusion devices
|
|
WO2013158309A2
(en)
*
|
2012-04-18 |
2013-10-24 |
The Board Of Trustees Of The Leland Stanford Junior University |
Non-disruptive gene targeting
|
|
BR112014026203A2
(pt)
|
2012-04-23 |
2017-07-18 |
Bayer Cropscience Nv |
engenharia do genoma direcionado nas plantas
|
|
HUE064187T2
(hu)
|
2012-05-25 |
2024-02-28 |
Cellectis |
Eljárás immunterápiára alkalmas allogén és immunszupresszív-rezisztens T-sejt módosítására
|
|
US20150017136A1
(en)
|
2013-07-15 |
2015-01-15 |
Cellectis |
Methods for engineering allogeneic and highly active t cell for immunotherapy
|
|
US9890364B2
(en)
|
2012-05-29 |
2018-02-13 |
The General Hospital Corporation |
TAL-Tet1 fusion proteins and methods of use thereof
|
|
US10815500B2
(en)
|
2012-06-05 |
2020-10-27 |
Cellectis |
Transcription activator-like effector (TALE) fusion protein
|
|
US20150225734A1
(en)
|
2012-06-19 |
2015-08-13 |
Regents Of The University Of Minnesota |
Gene targeting in plants using dna viruses
|
|
US9091827B2
(en)
|
2012-07-09 |
2015-07-28 |
Luxtera, Inc. |
Method and system for grating couplers incorporating perturbed waveguides
|
|
RU2663725C2
(ru)
|
2012-09-04 |
2018-08-08 |
Селлектис |
Многоцепочечный химерный антигенный рецептор и его применения
|
|
CN103668470B
(zh)
*
|
2012-09-12 |
2015-07-29 |
上海斯丹赛生物技术有限公司 |
一种dna文库及构建转录激活子样效应因子核酸酶质粒的方法
|
|
EP2906602B1
(en)
|
2012-10-12 |
2019-01-16 |
The General Hospital Corporation |
Transcription activator-like effector (tale) - lysine-specific demethylase 1 (lsd1) fusion proteins
|
|
JP6517143B2
(ja)
|
2012-10-23 |
2019-05-22 |
ツールゲン インコーポレイテッド |
標的ｄｎａに特異的なガイドｒｎａおよびｃａｓタンパク質コード核酸またはｃａｓタンパク質を含む、標的ｄｎａを切断するための組成物、ならびにその使用
|
|
WO2014071006A1
(en)
|
2012-10-31 |
2014-05-08 |
Cellectis |
Coupling herbicide resistance with targeted insertion of transgenes in plants
|
|
KR102315098B1
(ko)
*
|
2012-11-01 |
2021-10-21 |
팩터 바이오사이언스 인크. |
세포에서 단백질을 발현시키는 방법들과 생성물들
|
|
CA2891510C
(en)
|
2012-11-16 |
2022-10-18 |
Transposagen Biopharmaceuticals, Inc. |
Site-specific enzymes and methods of use
|
|
BR112015011190A2
(pt)
|
2012-11-16 |
2017-10-03 |
Total Marketing Services |
Método de modificação dirigida e célula de alga geneticamente modificada
|
|
WO2014102688A1
(en)
|
2012-12-27 |
2014-07-03 |
Cellectis |
New design matrix for improvement of homology-directed gene targeting
|
|
US20150376585A1
(en)
|
2013-02-01 |
2015-12-31 |
Cellectis |
Tevi chimeric endonuclease and their preferential cleavage sites
|
|
EP3623463B1
(en)
|
2013-02-07 |
2021-10-20 |
The General Hospital Corporation |
Tale transcriptional activators
|
|
WO2014128659A1
(en)
|
2013-02-21 |
2014-08-28 |
Cellectis |
Method to counter-select cells or organisms by linking loci to nuclease components
|
|
NZ712727A
(en)
*
|
2013-03-14 |
2017-05-26 |
Caribou Biosciences Inc |
Compositions and methods of nucleic acid-targeting nucleic acids
|
|
US9937207B2
(en)
|
2013-03-21 |
2018-04-10 |
Sangamo Therapeutics, Inc. |
Targeted disruption of T cell receptor genes using talens
|
|
US20160053274A1
(en)
|
2013-04-02 |
2016-02-25 |
Bayer Cropscience Nv |
Targeted genome engineering in eukaryotes
|
|
HK1214302A1
(zh)
*
|
2013-04-16 |
2016-07-22 |
深圳华大基因科技服务有限公司 |
分离的寡核苷酸及其用途
|
|
CN105378067A
(zh)
|
2013-05-13 |
2016-03-02 |
塞勒克提斯公司 |
工程化用于免疫治疗的高活性t细胞的方法
|
|
BR112015028387B1
(pt)
|
2013-05-13 |
2023-04-11 |
Cellectis |
Receptor antigênico quimérico específico para cd19, polinucleotídeo, vetor de expressão, método in vitro para manipulação e uso de uma célula imune
|
|
WO2014191527A1
(en)
*
|
2013-05-31 |
2014-12-04 |
Cellectis |
A laglidadg homing endonuclease cleaving the t cell receptor alpha gene and uses thereof
|
|
WO2014191525A1
(en)
*
|
2013-05-31 |
2014-12-04 |
Cellectis |
A laglidadg homing endonuclease cleaving the c-c chemokine receptor type-5 (ccr5) gene and uses thereof
|
|
JP2016521561A
(ja)
*
|
2013-06-14 |
2016-07-25 |
セレクティス |
植物における非トランスジェニックのゲノム編集のための方法
|
|
CA2915779A1
(en)
*
|
2013-06-25 |
2014-12-31 |
Cellectis |
Modified diatoms for biofuel production
|
|
FR3008106A1
(fr)
*
|
2013-07-05 |
2015-01-09 |
Agronomique Inst Nat Rech |
Methode d'induction d'une recombinaison meiotique ciblee
|
|
US10782479B2
(en)
|
2013-07-08 |
2020-09-22 |
Luxtera Llc |
Method and system for mode converters for grating couplers
|
|
US10006011B2
(en)
|
2013-08-09 |
2018-06-26 |
Hiroshima University |
Polypeptide containing DNA-binding domain
|
|
US20150044192A1
(en)
|
2013-08-09 |
2015-02-12 |
President And Fellows Of Harvard College |
Methods for identifying a target site of a cas9 nuclease
|
|
US9359599B2
(en)
*
|
2013-08-22 |
2016-06-07 |
President And Fellows Of Harvard College |
Engineered transcription activator-like effector (TALE) domains and uses thereof
|
|
US9737604B2
(en)
|
2013-09-06 |
2017-08-22 |
President And Fellows Of Harvard College |
Use of cationic lipids to deliver CAS9
|
|
US9228207B2
(en)
|
2013-09-06 |
2016-01-05 |
President And Fellows Of Harvard College |
Switchable gRNAs comprising aptamers
|
|
US9388430B2
(en)
|
2013-09-06 |
2016-07-12 |
President And Fellows Of Harvard College |
Cas9-recombinase fusion proteins and uses thereof
|
|
RU2670512C2
(ru)
*
|
2013-09-23 |
2018-10-23 |
Ренссилэйер Политекник Инститьют |
Доставка генов, опосредованная наночастицами, геномная коррекция и лиганд-направленная модификация в различных клеточных популяциях
|
|
US9476884B2
(en)
|
2013-10-04 |
2016-10-25 |
University Of Massachusetts |
Hybridization- independent labeling of repetitive DNA sequence in human chromosomes
|
|
EP3060658B1
(en)
*
|
2013-10-25 |
2020-07-15 |
Cellectis |
Design of rare-cutting endonucleases for efficient and specific targeting dna sequences comprising highly repetitive motives
|
|
CN111218447B
(zh)
|
2013-11-07 |
2024-10-11 |
爱迪塔斯医药有限公司 |
使用统治型gRNA的CRISPR相关方法和组合物
|
|
US11053481B2
(en)
|
2013-12-12 |
2021-07-06 |
President And Fellows Of Harvard College |
Fusions of Cas9 domains and nucleic acid-editing domains
|
|
CN105939767B
(zh)
|
2014-01-08 |
2018-04-06 |
弗洛设计声能学公司 |
具有双声电泳腔的声电泳装置
|
|
US10179911B2
(en)
|
2014-01-20 |
2019-01-15 |
President And Fellows Of Harvard College |
Negative selection and stringency modulation in continuous evolution systems
|
|
PT3105317T
(pt)
|
2014-02-14 |
2019-02-27 |
Cellectis |
Células para imunoterapia manipuladas para atuar sobre antigénios presentes tanto em células imunitárias como em células patológicas
|
|
EP3693384B1
(en)
|
2014-03-11 |
2024-01-24 |
Cellectis |
Method for generating t-cells compatible for allogenic transplantation
|
|
JP6689202B2
(ja)
|
2014-03-19 |
2020-04-28 |
セレクティスＣｅｌｌｅｃｔｉｓ |
癌免疫治療のためのｃｄ１２３特異的キメラ抗原受容体
|
|
KR102736149B1
(ko)
|
2014-03-21 |
2024-11-28 |
더 보드 어브 트러스티스 어브 더 리랜드 스탠포드 주니어 유니버시티 |
뉴클레아제 없는 게놈 편집
|
|
WO2015155341A1
(en)
|
2014-04-11 |
2015-10-15 |
Cellectis |
Method for generating immune cells resistant to arginine and/or tryptophan depleted microenvironment
|
|
WO2015195798A1
(en)
*
|
2014-06-17 |
2015-12-23 |
Poseida Therapeutics, Inc. |
A method for directing proteins to specific loci in the genome and uses thereof
|
|
ES2715413T3
(es)
|
2014-07-29 |
2019-06-04 |
Cellectis |
Receptores de antígeno quiméricos específicos para ROR1 (NTRKR1) para inmunoterapia contra el cáncer
|
|
AU2015298571B2
(en)
|
2014-07-30 |
2020-09-03 |
President And Fellows Of Harvard College |
Cas9 proteins including ligand-dependent inteins
|
|
EP3194432B1
(en)
|
2014-07-31 |
2019-04-10 |
Cellectis |
Ror1 specific multi-chain chimeric antigen receptor
|
|
JP6810685B2
(ja)
|
2014-09-04 |
2021-01-06 |
セレクティスＣｅｌｌｅｃｔｉｓ |
癌免疫療法のための栄養膜糖タンパク質（５ｔ４、ｔｐｂｇ）特異的キメラ抗原受容体
|
|
WO2016077052A2
(en)
|
2014-10-22 |
2016-05-19 |
President And Fellows Of Harvard College |
Evolution of proteases
|
|
KR102329836B1
(ko)
|
2015-01-26 |
2021-11-19 |
셀렉티스 |
암 면역치료를 위한 항-CLL1 특이적 단일-체인 키메라 항원 수용체들(scCARS)
|
|
CA2976376A1
(en)
|
2015-02-13 |
2016-08-18 |
Factor Bioscience Inc. |
Nucleic acid products and methods of administration thereof
|
|
US20160244784A1
(en)
*
|
2015-02-15 |
2016-08-25 |
Massachusetts Institute Of Technology |
Population-Hastened Assembly Genetic Engineering
|
|
BR112017018224A2
(pt)
|
2015-03-11 |
2018-04-17 |
Cellectis |
métodos para manipulação de célula t alogênica para aumentar sua persistência e/ou implante em pacientes
|
|
WO2016168631A1
(en)
|
2015-04-17 |
2016-10-20 |
President And Fellows Of Harvard College |
Vector-based mutagenesis system
|
|
US11377651B2
(en)
|
2016-10-19 |
2022-07-05 |
Flodesign Sonics, Inc. |
Cell therapy processes utilizing acoustophoresis
|
|
US11708572B2
(en)
|
2015-04-29 |
2023-07-25 |
Flodesign Sonics, Inc. |
Acoustic cell separation techniques and processes
|
|
US20180344817A1
(en)
*
|
2015-05-01 |
2018-12-06 |
Precision Biosciences, Inc. |
Precise deletion of chromosomal sequences in vivo and treatment of nucleotide repeat expansion disorders using engineered nucleases
|
|
EP3298046B1
(en)
|
2015-05-20 |
2025-02-12 |
Cellectis |
Anti-gd3 specific chimeric antigen receptors for cancer immunotherapy
|
|
AU2016278226B2
(en)
|
2015-06-17 |
2021-08-12 |
Poseida Therapeutics, Inc. |
Compositions and methods for directing proteins to specific loci in the genome
|
|
EP4043556B1
(en)
|
2015-06-30 |
2024-02-07 |
Cellectis |
Methods for improving functionality in nk cell by gene inactivation using specific endonuclease
|
|
US10392674B2
(en)
|
2015-07-22 |
2019-08-27 |
President And Fellows Of Harvard College |
Evolution of site-specific recombinases
|
|
US11524983B2
(en)
|
2015-07-23 |
2022-12-13 |
President And Fellows Of Harvard College |
Evolution of Bt toxins
|
|
WO2017019895A1
(en)
|
2015-07-30 |
2017-02-02 |
President And Fellows Of Harvard College |
Evolution of talens
|
|
CN104962523B
(zh)
|
2015-08-07 |
2018-05-25 |
苏州大学 |
一种测定非同源末端连接修复活性的方法
|
|
JP2018522907A
(ja)
|
2015-08-11 |
2018-08-16 |
セレクティスＣｅｌｌｅｃｔｉｓ |
Ｃｄ３８抗原を標的とするためおよびｃｄ３８遺伝子を不活化するために操作された、免疫療法用の細胞
|
|
US12043852B2
(en)
|
2015-10-23 |
2024-07-23 |
President And Fellows Of Harvard College |
Evolved Cas9 proteins for gene editing
|
|
WO2017079428A1
(en)
|
2015-11-04 |
2017-05-11 |
President And Fellows Of Harvard College |
Site specific germline modification
|
|
EP3429634A1
(en)
|
2016-04-15 |
2019-01-23 |
Cellectis |
A method of engineering prodrug-specific hypersensitive t-cells for immunotherapy by gene expression
|
|
US10894093B2
(en)
|
2016-04-15 |
2021-01-19 |
Cellectis |
Method of engineering drug-specific hypersensitive t-cells for immunotherapy by gene inactivation
|
|
US11214789B2
(en)
|
2016-05-03 |
2022-01-04 |
Flodesign Sonics, Inc. |
Concentration and washing of particles with acoustics
|
|
US11293033B2
(en)
|
2016-05-18 |
2022-04-05 |
Amyris, Inc. |
Compositions and methods for genomic integration of nucleic acids into exogenous landing pads
|
|
BR112018074101A2
(pt)
|
2016-05-26 |
2019-03-06 |
Nunhems Bv |
plantas produtoras de fruto sem semente
|
|
GB2568182A
(en)
|
2016-08-03 |
2019-05-08 |
Harvard College |
Adenosine nucleobase editors and uses thereof
|
|
WO2018031683A1
(en)
|
2016-08-09 |
2018-02-15 |
President And Fellows Of Harvard College |
Programmable cas9-recombinase fusion proteins and uses thereof
|
|
UY40583A
(es)
|
2016-08-17 |
2024-01-15 |
Monsanto Technology Llc |
MÉTODOS, COMPOSICIONES y PLANTAS MEDIANTE LA MANIPULACIÓN DEL METABOLISMO DE GIBERELINA PARA AUMENTAR EL RENDIMIENTO COSECHABLE
|
|
AU2017312113B2
(en)
|
2016-08-17 |
2023-05-25 |
Factor Bioscience Inc. |
Nucleic acid products and methods of administration thereof
|
|
US11542509B2
(en)
|
2016-08-24 |
2023-01-03 |
President And Fellows Of Harvard College |
Incorporation of unnatural amino acids into proteins using base editing
|
|
EP3757120B8
(en)
|
2016-10-04 |
2022-06-15 |
Precision Biosciences, Inc. |
Co-stimulatory domains for use in genetically-modified cells
|
|
GB2573062A
(en)
|
2016-10-14 |
2019-10-23 |
Harvard College |
AAV delivery of nucleobase editors
|
|
WO2018091971A1
(en)
*
|
2016-11-15 |
2018-05-24 |
Genomic Vision |
Method for the monitoring of modified nucleases induced-gene editing events by molecular combing
|
|
WO2018112282A1
(en)
|
2016-12-14 |
2018-06-21 |
Ligandal, Inc. |
Compositions and methods for nucleic acid and/or protein payload delivery
|
|
WO2018115189A1
(en)
|
2016-12-21 |
2018-06-28 |
Cellectis |
Stably enginereed proteasome inhibitor resistant immune cells for immunotherapy
|
|
WO2018119359A1
(en)
|
2016-12-23 |
2018-06-28 |
President And Fellows Of Harvard College |
Editing of ccr5 receptor gene to protect against hiv infection
|
|
US11898179B2
(en)
|
2017-03-09 |
2024-02-13 |
President And Fellows Of Harvard College |
Suppression of pain by gene editing
|
|
WO2018165631A1
(en)
|
2017-03-09 |
2018-09-13 |
President And Fellows Of Harvard College |
Cancer vaccine
|
|
US20200010519A1
(en)
|
2017-03-10 |
2020-01-09 |
Institut National De La Sante Et De La Recherche Medicale(Inserm) |
Nuclease fusions for enhancing genome editing by homology-directed transgene integration
|
|
CN110914310A
(zh)
|
2017-03-10 |
2020-03-24 |
哈佛大学的校长及成员们 |
胞嘧啶至鸟嘌呤碱基编辑器
|
|
JP6901293B2
(ja)
*
|
2017-03-15 |
2021-07-14 |
株式会社三共 |
遊技用装置
|
|
US11268082B2
(en)
|
2017-03-23 |
2022-03-08 |
President And Fellows Of Harvard College |
Nucleobase editors comprising nucleic acid programmable DNA binding proteins
|
|
PT3592379T
(pt)
|
2017-03-31 |
2024-05-31 |
Cellectis Sa |
Células imunitárias manipuladas universais dotadas de recetor antigénico quimérico anti-cd22
|
|
AU2018266698A1
(en)
|
2017-05-08 |
2019-11-28 |
Precision Biosciences, Inc. |
Nucleic acid molecules encoding an engineered antigen receptor and an inhibitory nucleic acid molecule and methods of use thereof
|
|
WO2018209320A1
(en)
|
2017-05-12 |
2018-11-15 |
President And Fellows Of Harvard College |
Aptazyme-embedded guide rnas for use with crispr-cas9 in genome editing and transcriptional activation
|
|
AU2018273979B2
(en)
|
2017-05-25 |
2024-10-17 |
Regeneron Pharmaceuticals, Inc. |
CBLB endonuclease variants, compositions, and methods of use
|
|
EP3645036A1
(en)
|
2017-06-30 |
2020-05-06 |
Cellectis |
Cellular immunotherapy for repetitive administration
|
|
US11447809B2
(en)
|
2017-07-06 |
2022-09-20 |
President And Fellows Of Harvard College |
Evolution of tRNA synthetases
|
|
JP2020534795A
(ja)
|
2017-07-28 |
2020-12-03 |
プレジデント アンド フェローズ オブ ハーバード カレッジ |
ファージによって支援される連続的進化（ｐａｃｅ）を用いて塩基編集因子を進化させるための方法および組成物
|
|
WO2019040935A1
(en)
|
2017-08-25 |
2019-02-28 |
President And Fellows Of Harvard College |
EVOLUTION OF PEPTIDASES BONT
|
|
WO2019139645A2
(en)
|
2017-08-30 |
2019-07-18 |
President And Fellows Of Harvard College |
High efficiency base editors comprising gam
|
|
WO2019056002A1
(en)
|
2017-09-18 |
2019-03-21 |
President And Fellows Of Harvard College |
CONTINUOUS EVOLUTION FOR STABILIZED PROTEINS
|
|
WO2019060631A1
(en)
*
|
2017-09-20 |
2019-03-28 |
Helix Nanotechnologies, Inc. |
EXPRESSION SYSTEMS THAT FACILITATE THE DELIVERY OF NUCLEIC ACIDS AND METHODS OF USE
|
|
US20200239544A1
(en)
|
2017-10-03 |
2020-07-30 |
Precision Biosciences, Inc. |
Modified epidermal growth factor receptor peptides for use in genetically-modified cells
|
|
WO2019072824A1
(en)
|
2017-10-09 |
2019-04-18 |
Cellectis |
IMPROVED ANTI-CD123 CAR IN UNIVERSAL MODIFIED IMMUNE T LYMPHOCYTES
|
|
CA3082251A1
(en)
|
2017-10-16 |
2019-04-25 |
The Broad Institute, Inc. |
Uses of adenosine base editors
|
|
BR112020009663A2
(pt)
|
2017-11-17 |
2020-11-10 |
Iovance Biotherapeutics, Inc. |
método para a expansão de linfócitos infiltrantes de tumor (tils) em uma população terapêutica de tils, método para o tratamento de um indivíduo com câncer, composição
|
|
EP3714041A1
(en)
|
2017-11-22 |
2020-09-30 |
Iovance Biotherapeutics, Inc. |
Expansion of peripheral blood lymphocytes (pbls) from peripheral blood
|
|
EP3725092A4
(en)
|
2017-12-14 |
2021-09-22 |
FloDesign Sonics, Inc. |
DRIVE AND CONTROL UNIT FOR ACOUSTIC CONVERTER
|
|
US12406749B2
(en)
|
2017-12-15 |
2025-09-02 |
The Broad Institute, Inc. |
Systems and methods for predicting repair outcomes in genetic engineering
|
|
EP3501268B1
(en)
|
2017-12-22 |
2021-09-15 |
KWS SAAT SE & Co. KGaA |
Regeneration of plants in the presence of histone deacetylase inhibitors
|
|
EP3508581A1
(en)
|
2018-01-03 |
2019-07-10 |
Kws Saat Se |
Regeneration of genetically modified plants
|
|
BR112020014168A2
(pt)
|
2018-01-12 |
2020-12-08 |
Basf Se |
Proteína, ácido nucleico isolado, gene recombinante, vetor, célula hospedeira, planta, parte de planta ou semente de trigo, métodos para produzir, produto de trigo, farinha, farelo integral, amido, grânulos de amido ou farelo de trigo e métodos para identificar e/ou selecionar uma planta de trigo
|
|
EP3694546A1
(en)
|
2018-01-30 |
2020-08-19 |
Cellectis |
Combination comprising allogeneic immune cells deficient for an antigen present on both t-cells and pathological cells and therapeutic antibody against said antigen
|
|
CN111727257A
(zh)
|
2018-02-15 |
2020-09-29 |
孟山都技术公司 |
通过性状堆叠提高作物产量的组合物和方法
|
|
EP3751987A4
(en)
|
2018-02-15 |
2021-11-10 |
Monsanto Technology LLC |
IMPROVED METHODS FOR MANUFACTURING HYBRID CORN SEEDS
|
|
EP3545756A1
(en)
|
2018-03-28 |
2019-10-02 |
KWS SAAT SE & Co. KGaA |
Regeneration of plants in the presence of inhibitors of the histone methyltransferase ezh2
|
|
JP7589047B2
(ja)
|
2018-04-05 |
2024-11-25 |
ジュノー セラピューティクス インコーポレイテッド |
組換え受容体を発現する細胞の作製方法および関連組成物
|
|
WO2019195491A1
(en)
|
2018-04-05 |
2019-10-10 |
Juno Therapeutics, Inc. |
T cells expressing a recombinant receptor, related polynucleotides and methods
|
|
US20210130779A1
(en)
|
2018-04-27 |
2021-05-06 |
Iovance Biotherapeutics, Inc. |
Closed process for expansion and gene editing of tumor infiltrating lymphocytes and uses of same in immunotherapy
|
|
EP3788154A1
(en)
|
2018-05-02 |
2021-03-10 |
Cellectis |
Engineering wheat with increased dietary fiber
|
|
HRP20251258T1
(hr)
|
2018-05-09 |
2025-12-05 |
KWS SAAT SE & Co. KGaA |
Gen za rezistenciju na patogen roda heterodera
|
|
US12157760B2
(en)
|
2018-05-23 |
2024-12-03 |
The Broad Institute, Inc. |
Base editors and uses thereof
|
|
US11913044B2
(en)
|
2018-06-14 |
2024-02-27 |
President And Fellows Of Harvard College |
Evolution of cytidine deaminases
|
|
EP4365194A3
(en)
|
2018-06-14 |
2024-07-24 |
Regeneron Pharmaceuticals, Inc. |
Cd79a chimeric antigen receptors
|
|
EP3806619A1
(en)
|
2018-06-15 |
2021-04-21 |
Nunhems B.V. |
Seedless watermelon plants comprising modifications in an abc transporter gene
|
|
WO2019238911A1
(en)
|
2018-06-15 |
2019-12-19 |
KWS SAAT SE & Co. KGaA |
Methods for improving genome engineering and regeneration in plant ii
|
|
CA3103564A1
(en)
|
2018-06-15 |
2019-12-19 |
KWS SAAT SE & Co. KGaA |
Methods for enhancing genome engineering efficiency
|
|
AU2019285083B2
(en)
|
2018-06-15 |
2024-01-25 |
KWS SAAT SE & Co. KGaA |
Methods for improving genome engineering and regeneration in plant
|
|
EP3817767A1
(en)
|
2018-07-02 |
2021-05-12 |
Cellectis |
Chimeric antigen receptors (car)-expressing cells and combination treatment for immunotherapy of patients with relapse refractory adverse genetic risk aml
|
|
EP3623379A1
(en)
|
2018-09-11 |
2020-03-18 |
KWS SAAT SE & Co. KGaA |
Beet necrotic yellow vein virus (bnyvv)-resistance modifying gene
|
|
WO2020072059A1
(en)
|
2018-10-04 |
2020-04-09 |
Bluebird Bio, Inc. |
Cblb endonuclease variants, compositions, and methods of use
|
|
WO2020092453A1
(en)
|
2018-10-29 |
2020-05-07 |
The Broad Institute, Inc. |
Nucleobase editors comprising geocas9 and uses thereof
|
|
MX2021004775A
(es)
|
2018-11-05 |
2021-06-08 |
Iovance Biotherapeutics Inc |
Expansion de linfocitos infiltrantes de tumores (tils) usando inhibidores de la via de proteina cinasa b (akt).
|
|
CA3118634A1
(en)
|
2018-11-05 |
2020-05-14 |
Iovance Biotherapeutics, Inc. |
Treatment of nsclc patients refractory for anti-pd-1 antibody
|
|
ES3036072T3
(en)
|
2018-11-05 |
2025-09-12 |
Iovance Biotherapeutics Inc |
Processes for production of tumor infiltrating lymphocytes and uses of the same in immunotherapy
|
|
SG11202104630PA
(en)
|
2018-11-05 |
2021-06-29 |
Iovance Biotherapeutics Inc |
Selection of improved tumor reactive t-cells
|
|
US12274205B2
(en)
|
2018-12-12 |
2025-04-15 |
Monsanto Technology Llc |
Delayed harvest of short stature corn plants
|
|
JP7710372B2
(ja)
|
2018-12-19 |
2025-07-18 |
アイオバンス バイオセラピューティクス，インコーポレイテッド |
操作されたサイトカイン受容体対を使用して腫瘍浸潤リンパ球を拡大培養する方法及びその使用
|
|
US20220090047A1
(en)
|
2018-12-21 |
2022-03-24 |
Precision Biosciences, Inc. |
Genetic modification of the hydroxyacid oxidase 1 gene for treatment of primary hyperoxaluria
|
|
US12351837B2
(en)
|
2019-01-23 |
2025-07-08 |
The Broad Institute, Inc. |
Supernegatively charged proteins and uses thereof
|
|
EP3918080A1
(en)
|
2019-01-29 |
2021-12-08 |
The University Of Warwick |
Methods for enhancing genome engineering efficiency
|
|
BR112021016875A2
(pt)
|
2019-03-01 |
2022-01-04 |
Iovance Biotherapeutics Inc |
Processo para expansão de linfócitos de sangue periférico
|
|
EP3708651A1
(en)
|
2019-03-12 |
2020-09-16 |
KWS SAAT SE & Co. KGaA |
Improving plant regeneration
|
|
AU2020240109A1
(en)
|
2019-03-19 |
2021-09-30 |
President And Fellows Of Harvard College |
Methods and compositions for editing nucleotide sequences
|
|
US11427814B2
(en)
|
2019-03-26 |
2022-08-30 |
Encodia, Inc. |
Modified cleavases, uses thereof and related kits
|
|
CN113993997A
(zh)
*
|
2019-03-26 |
2022-01-28 |
Encodia 公司 |
修饰的切割酶，及其使用和相关试剂盒
|
|
IL316764A
(en)
|
2019-04-03 |
2025-01-01 |
Prec Biosciences Inc |
Genetically modified immune cells containing shRNA-targeted microRNA (shRNAmir)
|
|
CA3136265A1
(en)
|
2019-04-05 |
2020-10-08 |
Precision Biosciences, Inc. |
Methods of preparing populations of genetically-modified immune cells
|
|
WO2020214842A1
(en)
|
2019-04-17 |
2020-10-22 |
The Broad Institute, Inc. |
Adenine base editors with reduced off-target effects
|
|
MX2021013223A
(es)
|
2019-05-01 |
2022-02-17 |
Juno Therapeutics Inc |
Celulas que expresan un receptor quimerico de un locus cd247 modificado, polinucleotidos relacionados y metodos.
|
|
CN114025788A
(zh)
|
2019-05-01 |
2022-02-08 |
朱诺治疗学股份有限公司 |
从经修饰的tgfbr2基因座表达重组受体的细胞、相关多核苷酸和方法
|
|
CA3138329A1
(en)
|
2019-05-10 |
2020-11-19 |
Basf Se |
Regulatory nucleic acid molecules for enhancing gene expression in plants
|
|
US11162079B2
(en)
|
2019-05-10 |
2021-11-02 |
The Regents Of The University Of California |
Blood type O Rh-hypo-immunogenic pluripotent cells
|
|
WO2020232029A1
(en)
|
2019-05-13 |
2020-11-19 |
Iovance Biotherapeutics, Inc. |
Methods and compositions for selecting tumor infiltrating lymphocytes and uses of the same in immunotherapy
|
|
EP3757219A1
(en)
|
2019-06-28 |
2020-12-30 |
KWS SAAT SE & Co. KGaA |
Enhanced plant regeneration and transformation by using grf1 booster gene
|
|
EP3997059A4
(en)
|
2019-07-03 |
2023-12-13 |
Factor Bioscience Inc. |
CATIONIC LIPIDS AND THEIR USES
|
|
EP4004216A1
(en)
|
2019-07-25 |
2022-06-01 |
Precision BioSciences, Inc. |
Compositions and methods for sequential stacking of nucleic acid sequences into a genomic locus
|
|
US10501404B1
(en)
|
2019-07-30 |
2019-12-10 |
Factor Bioscience Inc. |
Cationic lipids and transfection methods
|
|
US20220267732A1
(en)
|
2019-08-01 |
2022-08-25 |
Sana Biotechnology, Inc. |
Dux4 expressing cells and uses thereof
|
|
WO2021035054A1
(en)
|
2019-08-20 |
2021-02-25 |
Precision Biosciences, Inc. |
Lymphodepletion dosing regimens for cellular immunotherapies
|
|
WO2021035170A1
(en)
|
2019-08-21 |
2021-02-25 |
Precision Biosciences, Inc. |
Compositions and methods for tcr reprogramming using fusion proteins
|
|
JP7728747B2
(ja)
|
2019-08-23 |
2025-08-25 |
サナ バイオテクノロジー，インコーポレイテッド |
Ｃｄ２４発現細胞およびそれらの用途
|
|
US12492406B2
(en)
|
2019-09-12 |
2025-12-09 |
Basf Se |
Regulatory nucleic acid molecules for enhancing gene expression in plants
|
|
WO2021069387A1
(en)
|
2019-10-07 |
2021-04-15 |
Basf Se |
Regulatory nucleic acid molecules for enhancing gene expression in plants
|
|
US12435330B2
(en)
|
2019-10-10 |
2025-10-07 |
The Broad Institute, Inc. |
Methods and compositions for prime editing RNA
|
|
EP4048295A1
(en)
|
2019-10-25 |
2022-08-31 |
Iovance Biotherapeutics, Inc. |
Gene editing of tumor infiltrating lymphocytes and uses of same in immunotherapy
|
|
WO2021087305A1
(en)
|
2019-10-30 |
2021-05-06 |
Precision Biosciences, Inc. |
Cd20 chimeric antigen receptors and methods of use for immunotherapy
|
|
WO2021093943A1
(en)
|
2019-11-12 |
2021-05-20 |
KWS SAAT SE & Co. KGaA |
Gene for resistance to a pathogen of the genus heterodera
|
|
CN114787365A
(zh)
|
2019-12-03 |
2022-07-22 |
巴斯夫欧洲公司 |
用于在植物中增强基因表达的调节性核酸分子
|
|
WO2021113543A1
(en)
|
2019-12-06 |
2021-06-10 |
Precision Biosciences, Inc. |
Methods for cancer immunotherapy, using lymphodepletion regimens and cd19, cd20 or bcma allogeneic car t cells
|
|
JP7749561B2
(ja)
|
2019-12-11 |
2025-10-06 |
アイオバンス バイオセラピューティクス，インコーポレイテッド |
腫瘍浸潤リンパ球（ｔｉｌ）の産生のためのプロセス及びそれを使用する方法
|
|
WO2021146222A1
(en)
|
2020-01-13 |
2021-07-22 |
Sana Biotechnology, Inc. |
Modification of blood type antigens
|
|
TW202140784A
(zh)
|
2020-01-17 |
2021-11-01 |
美商薩那生物科技公司 |
用於調節基因表現的安全開關
|
|
WO2021158915A1
(en)
|
2020-02-06 |
2021-08-12 |
Precision Biosciences, Inc. |
Recombinant adeno-associated virus compositions and methods for producing and using the same
|
|
CN115605600A
(zh)
|
2020-02-28 |
2023-01-13 |
科沃施种子欧洲股份两合公司（De） |
未成熟花序分生组织编辑
|
|
CN115768446A
(zh)
|
2020-03-25 |
2023-03-07 |
萨那生物技术股份有限公司 |
用于治疗神经病症和疾患的低免疫原性神经细胞
|
|
US20230263121A1
(en)
|
2020-03-31 |
2023-08-24 |
Elo Life Systems |
Modulation of endogenous mogroside pathway genes in watermelon and other cucurbits
|
|
CA3176826A1
(en)
|
2020-05-04 |
2021-11-11 |
Iovance Biotherapeutics, Inc. |
Processes for production of tumor infiltrating lymphocytes and uses of the same in immunotherapy
|
|
BR112022022603A2
(pt)
|
2020-05-08 |
2023-01-17 |
Broad Inst Inc |
Métodos e composições para edição simultânea de ambas as fitas de sequência alvo de nucleotídeos de fita dupla
|
|
US20230183664A1
(en)
|
2020-05-11 |
2023-06-15 |
Precision Biosciences, Inc. |
Self-limiting viral vectors encoding nucleases
|
|
EP4149252A4
(en)
*
|
2020-05-12 |
2024-10-02 |
Factor Bioscience Inc. |
GENETICALLY ENGINEERED PROTEINS
|
|
KR20230022868A
(ko)
|
2020-05-13 |
2023-02-16 |
주노 쎄러퓨티크스 인코퍼레이티드 |
재조합 수용체를 발현하는 공여자-배치 세포의 제조 방법
|
|
US20240216508A1
(en)
|
2020-06-26 |
2024-07-04 |
Juno Therapeutics Gmbh |
Engineered t cells conditionally expressing a recombinant receptor, related polynucleotides and methods
|
|
EP4192875A1
(en)
|
2020-08-10 |
2023-06-14 |
Precision BioSciences, Inc. |
Antibodies and fragments specific for b-cell maturation antigen and uses thereof
|
|
EP4196568A1
(en)
|
2020-08-13 |
2023-06-21 |
Sana Biotechnology, Inc. |
Methods of treating sensitized patients with hypoimmunogenic cells, and associated methods and compositions
|
|
WO2022076606A1
(en)
|
2020-10-06 |
2022-04-14 |
Iovance Biotherapeutics, Inc. |
Treatment of nsclc patients with tumor infiltrating lymphocyte therapies
|
|
JP2023546359A
(ja)
|
2020-10-06 |
2023-11-02 |
アイオバンス バイオセラピューティクス，インコーポレイテッド |
腫瘍浸潤リンパ球療法によるｎｓｃｌｃ患者の治療
|
|
US20230365995A1
(en)
|
2020-10-07 |
2023-11-16 |
Precision Biosciences, Inc. |
Lipid nanoparticle compositions
|
|
CR20230175A
(es)
|
2020-10-23 |
2023-07-26 |
Elo Life Systems Inc |
Métodos para producir plantas de vainilla con mejor sabor y producción agronómica
|
|
EP4240756A1
(en)
|
2020-11-04 |
2023-09-13 |
Juno Therapeutics, Inc. |
Cells expressing a chimeric receptor from a modified invariant cd3 immunoglobulin superfamily chain locus and related polynucleotides and methods
|
|
US20240123067A1
(en)
|
2020-12-17 |
2024-04-18 |
Iovance Biotherapeutics, Inc. |
Treatment of cancers with tumor infiltrating lymphocyte therapies
|
|
US20240299539A1
(en)
|
2020-12-17 |
2024-09-12 |
Iovance Biotherapeutics, Inc. |
Treatment with tumor infiltrating lymphocyte therapies in combination with ctla-4 and pd-1 inhibitors
|
|
EP4019638A1
(en)
|
2020-12-22 |
2022-06-29 |
KWS SAAT SE & Co. KGaA |
Promoting regeneration and transformation in beta vulgaris
|
|
EP4019639A1
(en)
|
2020-12-22 |
2022-06-29 |
KWS SAAT SE & Co. KGaA |
Promoting regeneration and transformation in beta vulgaris
|
|
US11965022B2
(en)
|
2020-12-31 |
2024-04-23 |
Sana Biotechnology, Inc. |
Methods and compositions for modulating CAR-T activity
|
|
EP4284823A1
(en)
|
2021-01-28 |
2023-12-06 |
Precision BioSciences, Inc. |
Modulation of tgf beta signaling in genetically-modified eukaryotic cells
|
|
CA3206549A1
(en)
|
2021-01-29 |
2022-08-04 |
Frederick G. Vogt |
Methods of making modified tumor infiltrating lymphocytes and their use in adoptive cell therapy
|
|
TW202304480A
(zh)
|
2021-03-19 |
2023-02-01 |
美商艾歐凡斯生物治療公司 |
腫瘤浸潤淋巴球（ｔｉｌ）中之與ｃｄ３９／ｃｄ６９選擇及基因剔除相關之ｔｉｌ擴增之方法
|
|
EP4313122A1
(en)
|
2021-03-23 |
2024-02-07 |
Iovance Biotherapeutics, Inc. |
Cish gene editing of tumor infiltrating lymphocytes and uses of same in immunotherapy
|
|
TW202308669A
(zh)
|
2021-04-19 |
2023-03-01 |
美商艾歐凡斯生物治療公司 |
嵌合共刺激性受體、趨化激素受體及彼等於細胞免疫治療之用途
|
|
WO2022226316A1
(en)
|
2021-04-22 |
2022-10-27 |
Precision Biosciences, Inc. |
Compositions and methods for generating male sterile plants
|
|
US20240269180A1
(en)
|
2021-05-17 |
2024-08-15 |
Iovance Biotherapeutics, Inc. |
Pd-1 gene-edited tumor infiltrating lymphocytes and uses of same in immunotherapy
|
|
IL308097A
(en)
|
2021-05-27 |
2023-12-01 |
Sana Biotechnology Inc |
Hypoimmunogenic cells comprising engineered hla-e or hla-g
|
|
AU2022309875A1
(en)
|
2021-07-14 |
2024-01-25 |
Sana Biotechnology, Inc. |
Altered expression of y chromosome-linked antigens in hypoimmunogenic cells
|
|
CA3226111A1
(en)
|
2021-07-22 |
2023-01-26 |
Iovance Biotherapeutics, Inc. |
Method for cryopreservation of solid tumor fragments
|
|
CA3226942A1
(en)
|
2021-07-28 |
2023-02-02 |
Iovance Biotherapeutics, Inc. |
Treatment of cancer patients with tumor infiltrating lymphocyte therapies in combination with kras inhibitors
|
|
AU2022326565A1
(en)
|
2021-08-11 |
2024-02-08 |
Sana Biotechnology, Inc. |
Genetically modified cells for allogeneic cell therapy
|
|
JP2024534771A
(ja)
|
2021-08-11 |
2024-09-26 |
サナ バイオテクノロジー，インコーポレイテッド |
補体媒介性炎症反応を低減するための同種異系細胞療法のための遺伝子改変細胞
|
|
MX2024001208A
(es)
|
2021-08-11 |
2024-04-22 |
Sana Biotechnology Inc |
Celulas primarias geneticamente modificadas para terapia celular alogenica.
|
|
WO2023019225A2
(en)
|
2021-08-11 |
2023-02-16 |
Sana Biotechnology, Inc. |
Genetically modified cells for allogeneic cell therapy to reduce instant blood mediated inflammatory reactions
|
|
US20240424097A1
(en)
|
2021-09-09 |
2024-12-26 |
Iovance Biotherapeutics, Inc. |
Processes for generating til products using pd-1 talen knockdown
|
|
WO2023064872A1
(en)
|
2021-10-14 |
2023-04-20 |
Precision Biosciences, Inc. |
Combinations of anti-bcma car t cells and gamma secretase inhibitors
|
|
WO2023070003A1
(en)
|
2021-10-19 |
2023-04-27 |
Precision Biosciences, Inc. |
Gene editing methods for treating alpha-1 antitrypsin (aat) deficiency
|
|
CN113980141B
(zh)
*
|
2021-10-27 |
2022-11-29 |
湖北大学 |
基于大肠杆菌素e家族dna酶的蛋白质复合物及其在人工蛋白支架中的应用
|
|
TW202331735A
(zh)
|
2021-10-27 |
2023-08-01 |
美商艾歐凡斯生物治療公司 |
協調用於患者特異性免疫療法之細胞之製造的系統及方法
|
|
WO2023081767A1
(en)
|
2021-11-05 |
2023-05-11 |
Precision Biosciences, Inc. |
Methods for immunotherapy
|
|
WO2023081900A1
(en)
|
2021-11-08 |
2023-05-11 |
Juno Therapeutics, Inc. |
Engineered t cells expressing a recombinant t cell receptor (tcr) and related systems and methods
|
|
US11753677B2
(en)
|
2021-11-10 |
2023-09-12 |
Encodia, Inc. |
Methods for barcoding macromolecules in individual cells
|
|
US20250009800A1
(en)
|
2021-11-16 |
2025-01-09 |
Precision Biosciences, Inc. |
Methods for cancer immunotherapy
|
|
KR20240110844A
(ko)
|
2021-11-23 |
2024-07-16 |
셀렉티스 에스.에이. |
개선된 온-타겟/오프-타겟 활성 비율을 갖는 신규 tale 단백질 스캐폴드
|
|
WO2023133525A1
(en)
|
2022-01-07 |
2023-07-13 |
Precision Biosciences, Inc. |
Optimized polynucleotides for protein expression
|
|
WO2023147488A1
(en)
|
2022-01-28 |
2023-08-03 |
Iovance Biotherapeutics, Inc. |
Cytokine associated tumor infiltrating lymphocytes compositions and methods
|
|
AU2023220128A1
(en)
|
2022-02-17 |
2024-08-22 |
Sana Biotechnology, Inc. |
Engineered cd47 proteins and uses thereof
|
|
WO2023173123A1
(en)
|
2022-03-11 |
2023-09-14 |
Sana Biotechnology, Inc. |
Genetically modified cells and compositions and uses thereof
|
|
WO2023183313A1
(en)
|
2022-03-22 |
2023-09-28 |
Sana Biotechnology, Inc. |
Engineering cells with a transgene in b2m or ciita locus and associated compositions and methods
|
|
WO2023196877A1
(en)
|
2022-04-06 |
2023-10-12 |
Iovance Biotherapeutics, Inc. |
Treatment of nsclc patients with tumor infiltrating lymphocyte therapies
|
|
WO2023201369A1
(en)
|
2022-04-15 |
2023-10-19 |
Iovance Biotherapeutics, Inc. |
Til expansion processes using specific cytokine combinations and/or akti treatment
|
|
EP4522202A1
(en)
|
2022-05-10 |
2025-03-19 |
Iovance Biotherapeutics, Inc. |
Treatment of cancer patients with tumor infiltrating lymphocyte therapies in combination with an il-15r agonist
|
|
EP4583890A1
(en)
|
2022-09-09 |
2025-07-16 |
Iovance Biotherapeutics, Inc. |
Processes for generating til products using pd-1/tigit talen double knockdown
|
|
JP2025531877A
(ja)
|
2022-09-09 |
2025-09-25 |
アイオバンス バイオセラピューティクス，インコーポレイテッド |
Ｐｄ－１／ｔｉｇｉｔ ｔａｌｅｎダブルノックダウンを使用したｔｉｌ製品を生成するためのプロセス
|
|
EP4605524A1
(en)
|
2022-10-20 |
2025-08-27 |
Basf Se |
Regulatory nucleic acid molecules for enhancing gene expression in plants
|
|
WO2024097314A2
(en)
|
2022-11-02 |
2024-05-10 |
Sana Biotechnology, Inc. |
Methods and systems for determining donor cell features and formulating cell therapy products based on cell features
|
|
WO2024098024A1
(en)
|
2022-11-04 |
2024-05-10 |
Iovance Biotherapeutics, Inc. |
Expansion of tumor infiltrating lymphocytes from liquid tumors and therapeutic uses thereof
|
|
WO2024098027A1
(en)
|
2022-11-04 |
2024-05-10 |
Iovance Biotherapeutics, Inc. |
Methods for tumor infiltrating lymphocyte (til) expansion related to cd39/cd103 selection
|
|
WO2024100604A1
(en)
|
2022-11-09 |
2024-05-16 |
Juno Therapeutics Gmbh |
Methods for manufacturing engineered immune cells
|
|
IL320733A
(en)
|
2022-11-21 |
2025-07-01 |
Iovance Biotherapeutics Inc |
Two-dimensional processes for expanding tumor-infiltrating lymphocytes and treatments thereof
|
|
EP4623073A2
(en)
|
2022-11-21 |
2025-10-01 |
Iovance Biotherapeutics, Inc. |
Methods for assessing proliferation potency of gene-edited t cells
|
|
WO2024118836A1
(en)
|
2022-11-30 |
2024-06-06 |
Iovance Biotherapeutics, Inc. |
Processes for production of tumor infiltrating lymphocytes with shortened rep step
|
|
WO2024151541A1
(en)
|
2023-01-09 |
2024-07-18 |
Sana Biotechnology, Inc. |
Type-1 diabetes autoimmune mouse
|
|
CN121002052A
(zh)
|
2023-02-03 |
2025-11-21 |
C3S2 有限公司 |
用于非病毒生产工程化免疫细胞的方法
|
|
WO2024216116A1
(en)
|
2023-04-14 |
2024-10-17 |
Precision Biosciences, Inc. |
Muscle-specific expression cassettes
|
|
WO2024216118A1
(en)
|
2023-04-14 |
2024-10-17 |
Precision Biosciences, Inc. |
Muscle-specific expression cassettes
|
|
WO2024229302A1
(en)
|
2023-05-03 |
2024-11-07 |
Sana Biotechnology, Inc. |
Methods of dosing and administration of engineered islet cells
|
|
WO2024243236A2
(en)
|
2023-05-22 |
2024-11-28 |
Sana Biotechnology, Inc. |
Methods of delivery of islet cells and related methods
|
|
WO2025043172A1
(en)
|
2023-08-23 |
2025-02-27 |
Sana Biotechnology, Inc. |
Modified cd47 proteins and their uses
|
|
WO2025054540A1
(en)
|
2023-09-08 |
2025-03-13 |
Iovance Biotherapeutics, Inc. |
Methods of gene-editing using programmable nucleases
|
|
CN117344048A
(zh)
*
|
2023-09-28 |
2024-01-05 |
江苏省农业科学院 |
检测无毒基因Avr-Pik的RPA-LFD引物探针组、试剂盒及其应用
|
|
WO2025101484A1
(en)
|
2023-11-06 |
2025-05-15 |
Iovance Biotherapeutics, Inc. |
Treatment of endometrial cancers with tumor infiltrating lymphocyte therapies
|
|
CN117821413B
(zh)
*
|
2023-12-15 |
2024-12-27 |
湖北大学 |
一种高进行性Pfu DNA聚合酶及其制备方法和应用
|
|
WO2025137646A1
(en)
|
2023-12-22 |
2025-06-26 |
Recode Therapeutics, Inc. |
Gene editing methods and compositions for treating cystic fibrosis
|
|
WO2025181336A1
(en)
|
2024-03-01 |
2025-09-04 |
Cellectis Sa |
Compositions and methods for hbb-editing in hspc
|
|
WO2025212519A1
(en)
|
2024-04-01 |
2025-10-09 |
Moonlight Bio, Inc. |
Dll3 binding proteins and uses thereof
|
|
US20250345431A1
(en)
|
2024-05-10 |
2025-11-13 |
Juno Therapeutics, Inc. |
Genetically engineered t cells expressing a cd19 chimeric antigen receptor (car) and uses thereof for allogeneic cell therapy
|